DUPONT CAPITAL MANAGEMENT CORP - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 185 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$447,000
-52.2%
18,850
-44.6%
0.01%
-52.4%
Q3 2019$936,000
-24.9%
34,044
-9.7%
0.02%
-25.0%
Q2 2019$1,247,000
-5.6%
37,6940.0%0.03%
-6.7%
Q1 2019$1,321,000
+5.5%
37,6940.0%0.03%
-3.2%
Q4 2018$1,252,000
-18.8%
37,694
+23.1%
0.03%
-8.8%
Q3 2018$1,542,000
-15.9%
30,6210.0%0.03%
-20.9%
Q2 2018$1,833,000
+30.7%
30,6210.0%0.04%
+26.5%
Q1 2018$1,402,000
+322.3%
30,621
+267.8%
0.03%
+325.0%
Q4 2017$332,000
-0.3%
8,3260.0%0.01%0.0%
Q3 2017$333,000
-7.2%
8,3260.0%0.01%0.0%
Q2 2017$359,000
-27.5%
8,326
-58.4%
0.01%
-27.3%
Q3 2016$495,000
-70.3%
20,027
-75.5%
0.01%
-70.3%
Q2 2016$1,664,000
+33.5%
81,7010.0%0.04%
+32.1%
Q1 2016$1,246,000
+46.2%
81,701
+28.8%
0.03%
+33.3%
Q4 2015$852,000
-20.1%
63,414
-16.6%
0.02%
-22.2%
Q3 2015$1,067,000
-17.4%
76,0370.0%0.03%
-3.6%
Q2 2015$1,291,000
+252.7%
76,037
+151.0%
0.03%
+300.0%
Q1 2015$366,000
+45.8%
30,2990.0%0.01%
+40.0%
Q4 2014$251,000
-4.6%
30,2990.0%0.01%0.0%
Q3 2014$263,000
-24.9%
30,299
-5.3%
0.01%
-16.7%
Q2 2014$350,000
+34900.0%
31,999
+31899.0%
0.01%
Q1 2014$1,0000.0%1000.0%0.00%
Q4 2013$1,0001000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
NEA Management Company, LLC 7,641,250$107,207,0007.06%
HealthInvest Partners AB 782,746$10,982,0006.50%
KOPP INVESTMENT ADVISORS LLC 729,960$10,241,0005.51%
Murphy Michael R 1,028,304$14,427,0004.96%
Opaleye Management Inc. 460,000$6,454,0003.18%
ASHFORD CAPITAL MANAGEMENT INC 511,244$7,173,0001.68%
Bruce & Co., Inc. 394,581$5,535,0001.42%
AlphaOne Investment Services, LLC 235,065$3,297,0001.40%
Ranger Investment Management 1,560,453$21,893,0001.23%
NORTHPOINTE CAPITAL LLC 584,753$8,204,0001.07%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders